Your browser doesn't support javascript.
loading
Mortality in older patients admitted to an ICU for COVID-19: A systematic review.
Bianco, Céline; Guidet, Bertrand; Flaatten, Hans; Dechartres, Agnès; Vallet, Hélène.
Afiliação
  • Bianco C; Department of Geriatrics, Saint Antoine Hospital, APHP, Paris, France.
  • Guidet B; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Service de Réanimation Médicale, Hôpital Saint-Antoine, AP-HP, Paris, France.
  • Flaatten H; Department of Clinical Medicine, University of Bergen, Department of Research and Development, Haukeland University Hospital, Bergen, Norway.
  • Dechartres A; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP. Sorbonne Université, Hôpital Pitié Salpêtrière, Département de Santé Publique, Paris, France.
  • Vallet H; Sorbonne Université, INSERM, UMRS 1135, Centre d'immunologie et de Maladies Infectieuses (CIMI), Department of Geriatrics, Saint Antoine Hospital, APHP, Paris, France.
Acta Anaesthesiol Scand ; 67(9): 1140-1147, 2023 10.
Article em En | MEDLINE | ID: mdl-37323022
ABSTRACT

PURPOSE:

The objective was to conduct a systematic review of mortality and factors independently associated with mortality of older patients admitted to an intensive care unit (ICU) for COVID-19. MATERIALS AND

METHODS:

Data sources were MEDLINE, EMBASE, the Cochrane Library, and references of included studies. Two reviewers independently selected studies evaluating mortality of older patients (≥ 70 years) admitted to an ICU for COVID-19. They extracted general characteristics, mortality rate, and factors independently associated with mortality. The methodological quality of each study was evaluated by using the Critical Appraisal Skills Programme checklist.

RESULTS:

We selected 36 studies (11,989 patients). Many of the studies were conducted in Europe (42%) and many were retrospective (61%) and multicenter (61%). ICU mortality ranged from 8% to 90%, 1-month mortality from 33% to 90% and 3-month mortality, reported in five studies, from 46% to 60%. Frailty, assessed by the Clinical Frailty Score (CFS), was significantly associated with 1-month and 3-month mortality respectively in two studies (hazard ratio [HR] 3.2 [2.56-4.13] and HR 2.83 [95% CI 1.96-4.08]).

CONCLUSION:

In this systematic review of older patients admitted to an ICU with COVID-19, we documented high heterogeneity of mortality rates.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragilidade / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fragilidade / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article